Phescetam is combined medicinal product containing the active substances piracetam and cinnarizine. The combined product has a pronounced antihypoxic effect. The two active substances are mutually potentiated in relation to the reduction of cerebrovascular resistance. The combination increases cerebral blood flow.

Piracetam belongs to the group of so-called nootropic pharmaceuticals improving and restoring cognitive processes and mental capacity.

Cinnarizine is a selective blocker, suppressing calcium ion transport processes through cell membranes and leads to dilation of the blood vessels, reduces the excitability of the vestibular center, increases the resistance of the cells to oxygen insufficiency.

Phescetam is used in:

- Chronic and latent (concealed) cerebrovascular insufficiency in atherosclerosis and hypertension (high blood pressure); post-stroke conditions;

- Posttraumatic cerebrasthenia (post-concussion or mild brain injury);

- Encephalopathy (brain damage) of different origin;

- Psycho-organic syndrome with leading memory impairment and other cognitive functions;

- Labyrinthopathies and Meniere’s syndrome (inner ear damage) - vertigo, tinnitus, nausea, vomiting, nystagmus (involuntary eye movements);

- Prophylaxis of kinetosis (motion sickness).

Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.

Adults

1-2 capsules three times a day for 1 to 3 months, depending on the severity of the disease.

Use in children over 5 years of age - 1-2 capsules 1-2 times a day.

Elderly patients (over 65 years)

Prolonged treatment in elderly patients requires regular

control of creatinine clearance in order to adjust the dose as needed.

The product should not be used for more than 3 months without interruption.